Works matching IS 14642662 AND DT 2023 AND VI 24 AND IP 3
Results: 16
Serum globulin levels are associated with HIV reservoir size and immune restoration during long‐term ART.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 344, doi. 10.1111/hiv.13393
- By:
- Publication type:
- Article
Early culture conversion is a poor marker of treatment outcome among people with HIV and drug‐resistant TB.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 335, doi. 10.1111/hiv.13392
- By:
- Publication type:
- Article
Immune restoration affects 10‐year survival in people living with HIV/AIDS.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 325, doi. 10.1111/hiv.13391
- By:
- Publication type:
- Article
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 366, doi. 10.1111/hiv.13390
- By:
- Publication type:
- Article
Changing co‐morbidity and increasing deprivation among people living with HIV: UK population‐based cross‐sectional study.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 311, doi. 10.1111/hiv.13389
- By:
- Publication type:
- Article
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 301, doi. 10.1111/hiv.13388
- By:
- Publication type:
- Article
Editorial comment on: Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 245, doi. 10.1111/hiv.13387
- By:
- Publication type:
- Article
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 290, doi. 10.1111/hiv.13386
- By:
- Publication type:
- Article
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment‐naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 279, doi. 10.1111/hiv.13377
- By:
- Publication type:
- Article
Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 361, doi. 10.1111/hiv.13376
- By:
- Publication type:
- Article
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 267, doi. 10.1111/hiv.13373
- By:
- Publication type:
- Article
HBV, HCV, or syphilis coinfection with HIV in pregnant women seen at the main hospital in the capital of Venezuela.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Post‐partum contraception in women living with HIV.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 354, doi. 10.1111/hiv.13371
- By:
- Publication type:
- Article
Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 260, doi. 10.1111/hiv.13365
- By:
- Publication type:
- Article
Markers of ovarian reserve in women living with HIV: A systematic review.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 247, doi. 10.1111/hiv.13364
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 243, doi. 10.1111/hiv.13331
- Publication type:
- Article